Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Oncorena

    Client Virtual Booth

    ONCORENA

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Oncorena
    Sweden Flag
    Country
    Country
    Sweden
    Address
    Address
    Medicon Village, Scheeletorget 1 SE‑223 81 Lund
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.oncorena.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/oncorena-ab/
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Oncorena's first patient treated with ONC175 in clinical phase I/II trial
    Oncorena's first patient treated with ONC175 in clinical phase I/II trial

    https://www.prnewswire.com/news-releases/oncorenas-first-patient-treated-with-onc175-orellanine-in-clinical-phase-iii-trial-in-patients-with-metastatic-renal-cancer-and-dialysis-at-karolinska-university-hospital-in-stockholm-sweden-301916760.html

    PR NEWSWIRE
    04 Sep 2023
    Share Share
    Oncorena Initiates Phase I-II Clinical Trial with Orellanine
    Oncorena Initiates Phase I-II Clinical Trial with Orellanine

    https://www.biospace.com/article/releases/oncorena-initiates-the-phase-i-ii-clinical-trial-with-orellanine-in-advanced-kidney-cancer-patients-at-karolinska-university-hospital-in-sweden/

    BIOSPACE
    01 Feb 2022
    Share Share
    Oncorena Secures Financing of the Company's Continued Development of Orellanine
    Oncorena Secures Financing of the Company's Continued Development of Orellanine

    https://www.prnewswire.com/news-releases/oncorena-secures-financing-of-the-companys-continued-development-of-orellanine-a-potential-breakthrough-therapy-for-advanced-renal-cancer-301450285.html

    PRNEWSWIRE
    22 Dec 2021
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    polpharma-m-2024-04-15

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search